PNRAX
Price
$53.50
Change
+$0.54 (+1.02%)
Updated
Jun 6 closing price
Net Assets
576.03M
VITSX
Price
$143.69
Change
+$1.51 (+1.06%)
Updated
Jun 6 closing price
Net Assets
1.82T
Interact to see
Advertisement

PNRAX vs VITSX

Header iconPNRAX vs VITSX Comparison
Open Charts PNRAX vs VITSXBanner chart's image
Putnam Research A
Price$53.50
Change+$0.54 (+1.02%)
VolumeN/A
Net Assets576.03M
Vanguard Total Stock Market Idx I
Price$143.69
Change+$1.51 (+1.06%)
VolumeN/A
Net Assets1.82T
PNRAX vs VITSX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PNRAX vs. VITSX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PNRAX is a StrongBuy and VITSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VITSX has more cash in the bank: 1.82T vs. PNRAX (576M). VITSX pays higher dividends than PNRAX: VITSX (1.29) vs PNRAX (0.45). PNRAX was incepted earlier than VITSX: PNRAX (30 years) vs VITSX (28 years). PNRAX (1.01) is less costly to investors than VITSX (0.03). PNRAX is a more actively managed with annual turnover of: 35.00 vs. VITSX (2.00). PNRAX has a lower initial minimum investment than VITSX: PNRAX (0) vs VITSX (5000000). VITSX annual gain was more profitable for investors over the last year : 10.97 vs. PNRAX (2.94). VITSX return over 5 years is better than : 80.96 vs. PNRAX (58.64).
PNRAXVITSXPNRAX / VITSX
Total Expense Ratio1.010.033,367%
Annual Report Gross Expense Ratio1.010.033,367%
Fund Existence30 years28 years-
Gain YTD0.3410.83341%
Front Load6%N/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets576M1.82T0%
Annual Yield % from dividends0.451.2935%
Returns for 1 year2.9410.9727%
Returns for 3 years32.2040.3580%
Returns for 5 years58.6480.9672%
Returns for 10 years111.86180.4962%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LRMR2.680.22
+8.94%
Larimar Therapeutics
CATX3.320.20
+6.41%
Perspective Therapeutics
J127.672.67
+2.14%
Jacobs Solutions
HL6.27-0.18
-2.79%
Hecla Mining Company
CYCC0.37-0.24
-38.84%
Cyclacel Pharmaceuticals Inc.